Safety and Pharmacokinetic Study of TRX-818 in Asian Solid Tumor Patients
NCT02703298
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
19
Enrollment
INDUSTRY
Sponsor class
Conditions
Carcinoma
Advanced Cancer
Interventions
DRUG:
TRX-818 capsules
Sponsor
TaiRx, Inc.